Frontiers in Cancer Immunotherapy

Now in its 14th year, the Frontiers in Cancer Immunotherapy symposium serves as a pivotal gathering for leading researchers, clinicians, and industry innovators dedicated to exploring the next generation of therapies that are transforming cancer treatment. This annual event highlights the remarkable breakthroughs achieved in the field of immuno-oncology over the past decade while addressing the ongoing challenges faced in the field.

These include the complexities of resistant tumor types, the identification of novel therapeutic targets, and the development of effective strategies to overcome these hurdles.

The symposium will showcase cutting-edge research and promising approaches in various crucial areas including immunometabolism, resistance to immunotherapy, in vivo immune engineering, emerging therapeutic modalities, aging and immune dysfunction, and innovative cell therapy for acute myeloid leukemia (AML). Participants can look forward to an engaging program featuring keynote lectures and plenary talks, along with industry updates and short talks selected from submitted abstracts.

A panel discussion will also focus on strategies for translating discoveries from the laboratory to the clinic. The event promises ample networking opportunities, allowing attendees to connect with peers, collaborators, and leaders who are shaping the future of cancer immunotherapy. Held in New York City, this symposium is a unique chance to share knowledge, foster collaborations, and contribute to the ongoing conversation that drives breakthroughs in cancer treatment.

The mission of The New York Academy of Sciences, the organizing body, is to advance scientific research, education, and policy to address society's challenges. The Academy also publishes the Annals of the New York Academy of Sciences, a monthly international science journal recognized as one of the top multi-disciplinary journals worldwide. Additionally, the symposium aligns with the Blavatnik Awards for Young Scientists, which honors exceptional young scientists and engineers, celebrating their achievements and supporting innovation through unrestricted funding.

The event is designed to engage a diverse audience, primarily targeting professors and professionals within the USA.